Schmieder John Bradley's Form 4 filing
Mesa Laboratories Inc (MLAB) · filed Sep 19, 2023
- Accession no.
- 0001228924-23-000038
- Filed
- Sep 19, 2023
- Trade date
- Sep 14-15, 2023
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $492.9K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schmieder John BradleyCIK 0001637852 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2023 | Common Stock | SSaleDisposed | −3,000 | $123.05 | −$369,150 | 63,760 | Direct | |
| Sep 15, 2023 | Common Stock | SSaleDisposed | −1,000 | $123.74 | −$123,740 | 62,760 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.